Immunotherapy has become a promising approach for the treatment of cancer and other disorders of the immune system. Immune checkpoint blockade and adoptive cell transfer are two commonly used approaches. R&D Systems offers the proteins, antibodies, ELISAs, Luminex® assays, and other reagents needed to facilitate your research.
Browse our wide range of checkpoint blocking antibodies, checkpoint proteins, and assays.
Cell therapy workflow solutions include enrichment kits, GMP cytokines and growth factors, antibodies, and assays for functional identification.
Investigate how tumors create an immunosuppressive microenvironment.
Cell-based vaccines trigger cytolytic antigen-specific immune responses directed at thetumor cell target. We can provide tools to optimize and monitor the effectiveness of your vaccine research.
Offering the widest range of glycosidases and glucosyltransferases for manipulating glycan profiles.
Save time by letting our scientists develop antibodies, proteins, Luminex® panels, small molecules, and more.